🇺🇸
United States · US · US:0173-0887_3adf47cb-c3b5-4fdb-9441-d90679b79687
Trelegy Ellipta
In shortageOrange BookUNIISPLATC D07AC
Last synced from FDA National Drug Code directory (United States) on
Identification
ManufacturerGlaxoSmithKline LLC
CountryUS (United States)
ATC codeD07AC
Dispensing—
ReimbursedNo
SourceFDA National Drug Code directory (United States)
Last synced6/3/2026
Packs · 3
- ndc1101730887101 TRAY in 1 CARTON (0173-0887-10) / 1 INHALER in 1 TRAY / 30 POWDER in 1 INHALER
- ndc1101730887141 TRAY in 1 CARTON (0173-0887-14) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
- ndc1101730887611 TRAY in 1 CARTON (0173-0887-61) / 1 INHALER in 1 TRAY / 14 POWDER in 1 INHALER
Annotations
UNII (FDA Substance ID)
JS86977WNV
FLUTICASONE FUROATE
RxCUI 705022
Orange Book
N209482
DailyMed SPL labels
1 version tracked
FDA shortage
Currently in shortage
Fluticasone Propionate; Salmeterol Xinafoate Powder
Raw payload (JSON)
{
"unii": {
"unii": "JS86977WNV",
"rxcui": "705022",
"inchikey": "XTULMSXFIHGYFS-VLSRWLAYSA-N",
"display_name": "FLUTICASONE FUROATE",
"substance_type": "chemical",
"ingredient_type": "INGREDIENT SUBSTANCE"
},
"route": "RESPIRATORY (INHALATION)",
"spl_meta": {
"b5a81d5a-4648-4c7a-951d-33c014a63c7e": {
"match": "brand_token",
"title": "TRELEGY ELLIPTA (FLUTICASONE FUROATE, UMECLIDINIUM BROMIDE AND VILANTEROL TRIFENATATE) POWDER [GLAXOSMITHKLINE LLC]",
"spl_version": "14",
"published_date": "2025-11-19"
}
},
"productid": "0173-0887_3adf47cb-c3b5-4fdb-9441-d90679b79687",
"productndc": "0173-0887",
"dosage_form": "POWDER",
"orange_book": {
"appl_no": "209482",
"products": [
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "0.1MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH",
"product_no": "001",
"approval_date": "Sep 18, 2017"
},
{
"rs": true,
"rld": true,
"te_code": null,
"strength": "0.2MG/INH;EQ 0.0625MG BASE/INH;EQ 0.025MG BASE/INH",
"product_no": "002",
"approval_date": "Sep 9, 2020"
}
],
"appl_type": "N"
},
"dea_schedule": null,
"product_type": "HUMAN PRESCRIPTION DRUG",
"substance_name": "FLUTICASONE FUROATE; UMECLIDINIUM BROMIDE; VILANTEROL TRIFENATATE",
"shortage_reason": "Fluticasone Propionate; Salmeterol Xinafoate Powder",
"shortage_status": "current",
"proprietary_name": "Trelegy Ellipta",
"active_ingred_unit": "ug/1; ug/1; ug/1",
"application_number": "NDA209482",
"marketing_category": "NDA",
"nonproprietary_name": "fluticasone furoate, umeclidinium bromide and vilanterol trifenatate",
"start_marketing_date": "20170918",
"active_numerator_strength": "100; 62.5; 25"
}Related drugs
Other records sharing ATC code D07AC.
Access this data programmatically
Query Trelegy Ellipta and 610,000+ other drug records through a single REST API — with a last_synced_at provenance stamp on every response. Free tier includes 100 requests/day.